Old Web
English
Sign In
Acemap
>
authorDetail
>
Alyssa Nicotra
Alyssa Nicotra
Harvard University
Refractory
Ibrutinib
Internal medicine
Medicine
Immunology
3
Papers
85
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Umbralisib in combination with ibrutinib in patients with relapsed or refractory chronic lymphocytic leukaemia or mantle cell lymphoma: a multicentre phase 1–1b study
2019
The Lancet Haematology
Matthew S. Davids
Haesook T. Kim
Alyssa Nicotra
Alexandra Savell
Karen Francoeur
Jeffrey Hellman
Josie Bazemore
Hari P. Miskin
Peter Sportelli
Laura Stampleman
Rodrigo O. Maegawa
Jens Rueter
Adam M Boruchov
Jon E. Arnason
Caron A. Jacobson
Eric D. Jacobsen
David C. Fisher
Jennifer R. Brown
Show All
Source
Cite
Save
Citations (62)
UPDATED RESULTS OF A MULTICENTER PHASE I/IB STUDY OF TGR-1202 IN COMBINATION WITH IBRUTINIB IN PATIENTS WITH RELAPSED OR REFRACTORY MCL OR CLL
2017
Hematological Oncology
Matthew S. Davids
Haesook T. Kim
Alyssa Nicotra
Alexandra Savell
Karen Francoeur
Jeffrey Hellman
Hari P. Miskin
Peter Sportelli
Asad Bashey
Laura Stampleman
Jens Rueter
A. Boruchov
Jon E. Arnason
Caron A. Jacobson
E.J. Jacobsen
David C. Fisher
J.R. Brown
Show All
Source
Cite
Save
Citations (8)
TGR-1202 in Combination with Ibrutinib in Patients with Relapsed or Refractory CLL or MCL: Preliminary Results of a Multicenter Phase I/Ib Study
2016
Blood
Matthew S. Davids
Haesook T. Kim
Alyssa Nicotra
Alexandra Savell
Karen Francoeur
Jeffrey Hellman
Hari P. Miskin
Peter Sportelli
Asad Bashey
Laura Stampleman
Jens Rueter
Adam Boruchov
Jon E. Arnason
Caron A. Jacobson
David C. Fisher
Jennifer R. Brown
Show All
Source
Cite
Save
Citations (15)
1